Cargando…

Accrual mispricing, value-at-risk, and expected stock returns

We investigate the extent to which a parsimonious measure of maximum likely loss that captures the tail risk of returns—known as value-at-risk (VaR)—explains the relationship between accruals and the cross-sectional dispersion of expected stock returns. We construct portfolios based on Sloan’s (Acco...

Descripción completa

Detalles Bibliográficos
Autor principal: Simlai, Prodosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075029/
http://dx.doi.org/10.1007/s11156-021-00985-2
_version_ 1783684470752149504
author Simlai, Prodosh
author_facet Simlai, Prodosh
author_sort Simlai, Prodosh
collection PubMed
description We investigate the extent to which a parsimonious measure of maximum likely loss that captures the tail risk of returns—known as value-at-risk (VaR)—explains the relationship between accruals and the cross-sectional dispersion of expected stock returns. We construct portfolios based on Sloan’s (Account Rev 71(3):289–315, 1996) total accruals (TA) measure and individual asset-level VaR, which reflects the dynamic behavior of the asset distribution. We document that VaR is in congruence with portfolio-level accruals and that there is a significant positive relationship between VaR and the cross-section of portfolio returns. Allowing a double-sort involving VaR and TA further suggests that the spread between low- and high-TA portfolios is significantly attenuated after controlling for VaR. We also conduct a firm-level cross-sectional regression analysis and demonstrate that the TA- and VaR-based characteristics—but not the factor-mimicking portfolios—are compensated with higher expected returns, and that VaR neither subsumes nor is subsumed by TA. Finally, our cross-sectional decomposition analysis suggests that the firm-level VaR captures at least 7% of the accrual premium even in the presence of size and book-to-market. These findings lend support for the mispricing explanation of the accrual anomaly.
format Online
Article
Text
id pubmed-8075029
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-80750292021-04-27 Accrual mispricing, value-at-risk, and expected stock returns Simlai, Prodosh Rev Quant Finan Acc Original Research We investigate the extent to which a parsimonious measure of maximum likely loss that captures the tail risk of returns—known as value-at-risk (VaR)—explains the relationship between accruals and the cross-sectional dispersion of expected stock returns. We construct portfolios based on Sloan’s (Account Rev 71(3):289–315, 1996) total accruals (TA) measure and individual asset-level VaR, which reflects the dynamic behavior of the asset distribution. We document that VaR is in congruence with portfolio-level accruals and that there is a significant positive relationship between VaR and the cross-section of portfolio returns. Allowing a double-sort involving VaR and TA further suggests that the spread between low- and high-TA portfolios is significantly attenuated after controlling for VaR. We also conduct a firm-level cross-sectional regression analysis and demonstrate that the TA- and VaR-based characteristics—but not the factor-mimicking portfolios—are compensated with higher expected returns, and that VaR neither subsumes nor is subsumed by TA. Finally, our cross-sectional decomposition analysis suggests that the firm-level VaR captures at least 7% of the accrual premium even in the presence of size and book-to-market. These findings lend support for the mispricing explanation of the accrual anomaly. Springer US 2021-04-26 2021 /pmc/articles/PMC8075029/ http://dx.doi.org/10.1007/s11156-021-00985-2 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Research
Simlai, Prodosh
Accrual mispricing, value-at-risk, and expected stock returns
title Accrual mispricing, value-at-risk, and expected stock returns
title_full Accrual mispricing, value-at-risk, and expected stock returns
title_fullStr Accrual mispricing, value-at-risk, and expected stock returns
title_full_unstemmed Accrual mispricing, value-at-risk, and expected stock returns
title_short Accrual mispricing, value-at-risk, and expected stock returns
title_sort accrual mispricing, value-at-risk, and expected stock returns
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075029/
http://dx.doi.org/10.1007/s11156-021-00985-2
work_keys_str_mv AT simlaiprodosh accrualmispricingvalueatriskandexpectedstockreturns